Mumbai, May 22, 2026: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported financials for the fourth quarter ending March 31st, 2026. Highlights of Q4FY26 consolidated financials Sales at 145,598 million, a growth of 13.6% Global Innovative Medicines** sales at US$ 354 Global Innovative Medicines sales up 1%, accounting for […]